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Abstract: Escherichia coli is considered one of the most common agents associated with neonatal
diarrhea in piglets. The aim of this work was to characterize the pathogenic and antimicrobial
resistance (AMR) profiles of 122 E. coli strains isolated from pigs suffering diarrhea (n = 94) and pigs
without diarrhea (n = 28) of 24 farms in Spain. Virulence factors, toxins and AMR (ESBL and colistin)
genes and AMR phenotypes of E. coli isolates were analyzed. Low prevalence of pathogenic E. coli
strains (26%) was found in both groups. However, ETEC and VTEC strains were more frequently
isolated from diarrheic piglets. Irrespectively of diarrhea occurrence, 97.5% of the strains showed a
multidrug-resistance (MDR) profile to aminopenicillins, sulfonamides and tetracyclines. It was found
that 22% of E. coli was CTX-M+, with CTX-M-14 being the principal allelic variant. Remarkably,
81.5% of CTX-M+ strains were isolated from diarrheic animals and presented an extended MDR
profile to aminopenicillins, quinolones and aminoglycosides. Finally, low frequencies of colistin
resistance genes mcr-1 (4/122) and mcr-4 (1/122) were found. MDR E. coli strains are circulating in
pig farms of Spain, representing a serious threat to animal and public health. More appropriate
diagnostic approaches (genetic and AMR phenotypic analysis) should be implemented in animal
health to optimize antibiotic treatments.
Keywords: antimicrobial resistance; ESBL genes; colistin resistance; Escherichia coli; neonatal
diarrhea; pig
1. Introduction
Escherichia coli has historically been considered as one of the most common agents associated
with diarrhea in suckling and post-weaned piglets [1]. There is high diversity and variants of E. coli
strains integrating the normal gut microbiota, with most of them being considered not pathogenic [2].
The characterization of pathogenic E. coli strains is usually based on the presence of virulence factors [3].
In piglets, E. coli pathogenic strains can be classified into different pathotypes: enterotoxigenic
(ETEC) strains releasing heat-labile (LT) and heat-stable Sta and Stb exotoxins, intimin (eae)-producing
enteropathogenic (EPEC) strains and verotoxigenic (VTEC) strains producing VT1/VT2 verotoxins [4].
The routine use of antimicrobials in livestock, especially in the pig industry, for either ‘prophylaxis’
or ‘metaphylaxis’ represents a serious hazard for the selection of multidrug-resistant (MDR)
Vet. Sci. 2020, 7, 48; doi:10.3390/vetsci7020048 www.mdpi.com/journal/vetsci
Vet. Sci. 2020, 7, 48 2 of 12
Enterobacteriaceae strains [5,6]. In fact, the effectiveness of treatments against E. coli is threatened by the
dramatic increase of extended-spectrum beta-lactamases (ESBL)-producing isolates worldwide [7–9].
A high number of ESBL have been described and designated according to the strains of bacteria
or plasmid that produce them by using letters that usually evoke the name of the target antibiotic,
but they are also named after substrates, their biochemical properties, location of their discovery
and the name of the patient or the discovering investigators [10]. Genes encoding ESBL enzymes
are usually located in plasmids and can be easily horizontally transferred among different bacterial
populations. Most ESBL derive from the first enzymes discovered, TEM (named after the patient
(Temoneira) providing the first sample) and SHV (sulfhydryl reagent variable), which confer resistance
to beta-lactams such as ampicillin or amoxicillin. The most recent ESBLs are derived from the CTX-M
(active on cefotaxime-Munich) enzymes, which confer resistance to third- and fourth-generation
cephalosporins [10,11]. Cephalosporins constitute one of the largest families of antimicrobials widely
used in both human and veterinary medicine [12]. On the other hand, in veterinary medicine, colistin
sulfate is indicated for the treatment of Enterobacteriaceae infections and has been widely used as a
preventive mass-medication of colibacillosis in piglets [13]. Although colistin is one of the antimicrobial
agents with the lowest rates of resistance, the emergence of the mcr-1 (mobile colistin resistant) plasmid
in the Enterobacteriaceae population has resulted in the appearance of strains with acquired resistance to
this antibiotic [14,15]. In order to stop the increase of colistin-resistant strains, the European Medicines
Agency established in 2016 that all EU members should restrict and reduce the use of colistin in animals
for treating infections with a target level of 5 mg/PCU, where PCU refers to the ‘population correction
unit’ and takes into account the animal population as well as the estimated weight of each particular
animal at the time of treatment with antimicrobials. [16].
During recent decades, the importance of E. coli in porcine neonatal diarrhea seems to have
decreased [17], possibly due to the successful vaccination plans implemented in the pig farms [18].
Therefore, antimicrobial treatment might not be required in most cases of diarrhea, especially in those
where the role of the E. coli is not well defined. However, the systematic mass-medication of piglets
suffering from diarrheic processes is still common in many cases.
The aim of the present work was to characterize the virulence factors and to determine the
genotypic and phenotypic antimicrobial resistance patterns of E. coli isolates from cases of neonatal
diarrhea in conventional pig farms of Catalonia (Spain). Moreover, in order to assess the clinical
relevance of all isolates, samples from non-diarrheic pen-mates were also analyzed and compared to
the clinical cases.
2. Materials and Methods
2.1. Microbiological Testing
A total of 122 E. coli isolates obtained from 24 conventional Spanish farms suffering neonatal
diarrhea outbreaks during 2017 and 2018 were recovered from a previous study [19]. All the studied
farms were located in Catalonia (NE of Spain), the Spanish region with the greatest number of production
farms and one of the highest pig-density (242 animals/km2) regions in Europe. The sampling procedure
included 5–10 samples from diarrheic animals and 3–5 samples from apparently healthy pen-mates for
each farm. One gram of fecal sample was obtained directly from the animals using rectal swabs and
submitted for diagnostic testing to the Laboratori Veterinari de Diagnosi de Malalties Infeccioses of
the Universitat Autònoma de Barcelona (Spain). Besides E. coli, all samples were tested for a panel
of enteric infectious agents which comprised C. perfringens types A and C toxins (Cpα, Cpβ, Cpβ2);
C. difficile toxins (TcdA, TcdB); rotavirus A (RVA), B (RVB) and C (RVC); porcine epidemic diarrhea
virus (PEDV) and transmissible gastroenteritis virus (TGEV), and these general results were described
elsewhere [19].
For E. coli isolation, stool samples were cultured in standard Blood Agar (BD GmbH, Germany)
and MacConkey Agar (Oxoid, UK) and aerobically incubated at 37 ◦C for 24 h. A total of 122 pure
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isolates were collected: 94 from diarrheic samples of 1-week-old diseased piglets and 28 from feces of
apparently healthy pen-mates. All strains were confirmed as E. coli using conventional biochemical
tests. Only E. coli strains obtained as pure cultures from a direct seeding of feces were used for the
characterization, since the lack of microbial diversity was considered abnormal.
2.2. Characterization of E. coli Virulence Factors and Toxins
The presence of E. coli toxins (Sta, Stb, LT, EAST1, VT1 and VT2), fimbrial adhesins (F4, F5, F6,
F18 and F41) and non-fimbrial adhesin eae genes was analyzed by qualitative PCR, as described by
Toledo et al. (2012) with slight modifications [20]. Briefly, PCR assays were carried out using the Biotaq
DNA polymerase kit (Biotaq, Ecogen) using previously described primers [19]. The final 25 µL mixture
consisted of: 1× PCR Buffer, 0.8 mM of the dNTP mix, 3 mM of MgCl2, 1 mM of each primer and 1 U
of Taq polymerase. As template, 2.5 µL of the DNA sample was used. The PCR program consisted
of 5 min at 94 ◦C, followed by 30 cycles of 1 min at 94 ◦C, 1 min of annealing at 57 ◦C and 1 min of
extension at 72 ◦C, and a final extension step of 7 min at 72 ◦C. Positive and negative (ultrapure water)
controls were included in each run and particular care was taken to prevent carry-over contamination.
Reference E. coli strains used as positive controls were FV12048 (F4+ LT+ EAST1+), FV9722 (F5+
F41+), FV7633 (F6+), FV12047 (F18+ Sta+ Stb+) and O157-84 (eae+ VT1+ VT2+) were kindly donated
by Dr. Blanco (E. coli Reference Laboratory, Santiago de Compostela, Spain).
2.3. Antimicrobial Resistance Phenotyping Analyses
Antimicrobial susceptibility of E. coli isolates was tested using the disk diffusion method [21].
Briefly, one to four colonies were suspended in 5 mL of distilled sterile water to achieve a
turbidity of 0.5 in the McFarland scale. The dilution was then seeded onto Mueller–Hinton (Oxoid,
UK) plates. Each isolate was tested for the following antimicrobial groups, using commercial
disks: aminopenicillins (ampicillin, amoxicillin and amoxicillin/clavulanic acid); cephalosporins
(ceftiofur, cephalexin, cefquinome, ceftriaxone); quinolones (ciprofloxacin, enrofloxacin, flumequine);
aminoglycosides (gentamicin, neomycin, streptomycin, apramycin); tetracyclines (tetracycline,
doxycycline); sulfonamides (sulfonamide, sulfamethoxazole/trimethoprim); florfenicol; colistin;
lincospectin. Concentration of the commercial disks and breakpoints for each antimicrobial are
shown in Table 1.
Table 1. Concentrations and breakpoints of the antibiotic disks used for the disk diffusion method.
Antibiotic a
Concentration (µg/mg)
(Brand, Country)
Breakpoint (mm)
Reference b
S R
Amoxicillin (AMX) 25 (BD, USA) ≥17 ≤13 CLSI M100; human [21]
Amoxicillin/clavulanic
(AXC) 20/10 (Oxoid, UK) ≥18 ≤13 CLSI M100; human [21]
Ampicillin (AMP) 10 (BD, USA) ≥17 ≤13 CLSI VET08; dog [22]
Ceftiofur (CEFT) 30 (BD, USA) ≥21 ≤17
CLSI VET08; cattle E. coli
and swine Salmonella
Cholerasuis [22]
Cephalexin (CFL) 30 (Oxoid, UK) ≥18 ≤14 CLSI VET08; dog [22]
Cefquinome (CFQ) 10 (Conda Lab, Spain) ≥21 ≤17 CLSI VET08 [22]
Ceftriaxone (CFX) 30 (BD, USA) ≥21 ≤13 CLSI VET08 [22]
Ciprofloxacin (CIP) 5 (BD, USA ≥21 ≤15 CLSI M100; human [21]
Enrofloxacin (ENR) 5 (BD, USA) ≥23 ≤16 CLSI VET08; dog, cat andpoultry [22]
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Table 1. Cont.
Antibiotic a
Concentration (µg/mg)
(Brand, Country)
Breakpoint (mm)
Reference b
S R
Flumequine (FLU) 30 (BD, USA) ≥25 <21 EUCAST [23]
Gentamicin (GEN) 10 (BD, USA) ≥16 ≤12 CLSI VET08: dog, horse [22]
Neomycin (NEO) 30 (BD, USA) ≥17 ≤12 CLSI VET08 [22]
Streptomycin (STR) 10 (BD, USA) ≥15 ≤11 CLSI M100; human [21]
Apramycin (APR) 15 (Oxoid, UK) ≥15 ≤10 CLSI VET08 [22]
Tetracycline (TET) 30 (BD, USA) ≥15 ≤11 CLSI M100; human [21]
Doxycycline (DOX) 30 (Oxoid, UK) ≥16 ≤12 CLSI VET08; horse [22]
Sulfonamide (SULF) 300 (Oxoid, UK) ≥17 ≤12 EUCAST [23]
Sulfamethoxazole/
trimethoprim (SXT) 23.75 + 1.25 (BD, USA) ≥16 ≤10 CLSI VET08 [22]
Florfenicol (FF) 30 (Oxoid, UK) ≥22 ≤18 CLSI VET08; swine [22]
Colistin (CLT) 50 (BD, USA) ≥18 <15 CA-SFM, veterinary c [24]
Lincospectin (LS) 2 (Oxoid, UK) ≥20 ≤16 EUCAST [23]
a Antibiotic and abbreviations used also in Figures 1 and 2. b CLSI veterinary breakpoints were preferably used.
If not available, CLSI human, EUCAST or CA-SFM veterinary breakpoints were used. c The measurement of the
minimum inhibitory concentration of colistin in broth dilution remains the reference method.
Additionally, minimum inhibitory concentration (MIC) test was performed in order to evaluate
antimicrobial susceptibility to colistin, using the broth microdilution method in 96-well plates [22].
E. coli ATCC 25,922 was used as the quality control strain. Briefly, the tested colistin concentrations
ranged from 0.25 to 8 µg/mL. The tested strains were considered resistant when their MIC value was
higher than the wild type cut-off value (MIC > 2µg/mL) [23].
2.4. Genetic Characterization of Antimicrobial Resistance Genes
Molecular diagnosis of AMR genes was performed for the ESBL genes blaSHV, blaCTX-M,
blaCMY1, blaCMY2 and blaTEM; carbapenemase blaOXA and mcr-1 to mcr-5 colistin-resistance genes [25].
PCR conditions were homogenized for all the reactions as follows: 5 min at 94 ◦C, followed by 25 cycles
of 1 min at 94 ◦C, 1 min of annealing at 55 ◦C and 1 min of extension at 72 ◦C, and a final extension
step of 7 min at 72 ◦C. Amplified PCR products were Sanger sequenced for verification at the Genomic
and Bioinformatics Service of the Universitat Autònoma de Barcelona (Barcelona, Spain). Sequences
and chromatograms were manually explored to trim bad-quality bases using the BioEdit software.
The obtained sequences were aligned using Clustal Omega and blasted against those described at the
National Center for Biotechnology Information (NCBI) database.
2.5. Statistical Analysis
Chi-squared or Fisher exact tests were used for comparison between proportions when appropriate.
Results were considered statistically significant when p < 0.05.
3. Results
3.1. Microbiological Identification and Characterization of E. coli Isolates
Most of the E. coli isolates presented a very low prevalence of virulence factors and toxins (<5%).
with the exception of EAST1, which was present in more than 70% of the strains (Table 2). Moreover,
74% of the strains were negative for all toxins and intimin (eae) genes. As such, it was not possible to
classify them into any pathotype.
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Table 2. Comparison of virulence factors and pathogenic E. coli prevalence in diarrheic (n = 94) and
non-diarrheic (n = 28) pig groups.
Virulence Factors/Toxins 1 Diarrheic n = 94 Non-Diarrheic n = 28
n (%) n (%)
LT 2 (2.1) 0
Sta 4 (4.3) 0
Stb 12 (12.8) 1 (3.5)
EAST1 66 (70.2) 24 (85.7)
VT1 1 (1.1) 0
VT2 3 (3.2) 0
F4 4 (4.3) 0
F5 0 0
F6 0 0
F18 1 (1.1) 1 (3.5)
F41 3 (3.2) 1 (3.5)
eae 11 (11.8) 6 (21.4)
1 E. coli toxins (LT, Sta, Stb, EAST1, VT1 and VT2), fimbrial adhesins (F4, F5, F6, F18 and F41) and non-fimbrial
adhesin eae genes.
Table 3 shows the number of isolates presenting virulence factors and toxins grouped by pathotype
and their total frequency in diarrheic and not diarrheic cases. The most common pathotypes within
the classified strains were EPEC (n = 17) and ETEC (n = 15), with the frequency of EPEC being two
times higher (21% vs. 10.6%) in non-diarrheic piglets. As expected, the frequency of ETEC was higher
in animals presenting diarrhea than in those without clinical signs (15% vs. 3.5%). The presence of
VTEC (4.3%) was only detected in cases of diarrhea. Similarly, E. coli strains positive for F4, LT, Sta,
VT1 and VT2 genes were only isolated from clinical cases.
Table 3. Description of the profiles of virulence factor production and classification of the toxigenic
strains into pathotypes of E. coli strains.
Pathotype 1 Diarrheic (n = 94) Non-Diarrheic (n = 28) Total (n = 122)
ETEC (n = 11)
Stb+, EAST1+ 6 1 7
Stb+, EAST1+, Sta+ 1 0 1
Stb+, EAST1+, Sta+, F4+ 2 0 2
LT+ 1 0 1
LT+, EAST1+
Total n (%)
1
11 (11.7%)
0
1 (3.5%)
1
12 (9.8%)
ETEC/EPEC (n = 1)
Stb+, eae+, EAST1+, F41+
Total n (%)
1
1 (1.1%)
0
0
1
1 (0.8)
EPEC (n = 16)
eae+ 1 0 1
eae+, EAST1+ 7 5 12
eae+, EAST1+, F41+ 1 1 2
eae+, EAST1+, F18+
Total n (%)
1
10 (10.6%)
0
6 (21%)
1
16 (13.1%)
VTEC (n = 1)
VT1+
Total n (%)
1
1 (1.1%)
0
0
1
1 (0.8)
VTEC/ETEC (n = 3)
Stb+, VT2+ 1 0 1
Stb+, VT2+, EAST1+ 1 0 1
Stb+, VT2+, EAST1+, Sta+, F4+
Total n (%)
1
3 (3.2%)
0
0
1
3 (2.5%)
1 Enterotoxigenic (ETEC) strains releasing heat-labile LT and heat-stable Sta and Stb exotoxins; intimin (eae)-producing
enteropathogenic (EPEC) strains; verotoxigenic (VTEC) strains producing VT1/VT2 verotoxins.
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3.2. Antimicrobial Resistance Phenotyping and Genotyping
According to the results obtained by the disk diffusion method, the overall prevalence of AMR
in E. coli isolates was very high for most of the nine tested antimicrobial classes. The highest rates of
resistance were found for sulfonamides (87.3%), tetracyclines (87.3%) and aminopenicillins (80.1%),
followed by quinolones (49%), cephalosporins (32.9%) and aminoglycosides (27.9%). By contrast,
low resistance levels were observed for colistin (6.5%) and apramycin (5.9%). Regarding the MIC
results, 6 out of 122 (5%) were resistant to colistin (MIC > 2 µg/mL): 5 of them had an MIC value of
4 µg/mL, and one isolate had an MIC of 8 µg/mL. Comparing the colistin results obtained by disk
diffusion and the MIC, only one strain was considered resistant to colistin by both methods.
Most of the strains, 97.5% (119/122), presented a multidrug-resistance (MDR) profile
(≥3 antimicrobial categories), and 67.2% of them offered resistance to six antibiotic classes. Moreover,
30% of the strains (37/122) showed an extensive drug-resistance (XDR) profile (>7 antimicrobial classes).
Two strains presented resistance to all the tested antimicrobials except for colistin.
The comparison study between E. coli isolates from diarrheic and non-diarrheic samples showed
statistical differences in the proportion of AMR E. coli isolates (Figure 1). Remarkably, piglets presenting
diarrhea had higher prevalence of E. coli strains resistant to quinolones and aminoglycosides (gentamicin
and neomycin) compared to the non-diarrheic isolates (Fisher exact test p < 0.05).
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Figure 1. Antimicrobial resistance of E. coli strains from diarrheic and non-diarrheic groups. * Statistical
differences between diarrheic and non-diarrheic animals (Fisher exact test p < 0.05). Antibiotic
abbreviations are shown in Table 1.
The most prevalent ESBL gene was the blaCTX-M found in 22% (27/122) of the total samples,
and 81.5% (22/27) of them were isolated from diarrheic animals. All the CTX-M+ strains except
one were successfully sequenced and could be classified into the following blaCTX-M genotypes:
CTX-M-14 (38.5%), CTX-M-1 (19.2%), CTX-M-15 (19.2%), CTX-M-32 (11.5%), CTX-M-27 (7.7%) and
CTX-M-3 (3.8%).
On the other hand, E. coli harboring CTX-M+ genes presented a wider resistance pattern than those
CTX-M-negative strains (CTX-M–). Specifically, 81.5% of the CTX-M+ strains showed resistance to more
than 10 antimicrobials, while in the case of CTX-M– the percentage was 37.9%. Statistical differences
between CTX-M+ and CTX-M– strains were found for amoxicillin/clavulanic acid, cephalosporins,
quinolones and gentamicin drugs (Figure 2). By contrast, colistin resistance genes were detected in
a low proportion of cases: four strains harbored the mcr-1 gene (3%), and one strain was positive to
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mcr-4. Only one of the mcr-1+ strains, isolated from a diarrheic animal, exhibited phenotypic resistance
to colistin in the MIC test (8 µg/mL).
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4. Discussion
The aim of this work was to characterize the E. coli strains involved in porcine neonatal diarrhea
outbreaks by genotyping and phenotyping isolates grown as pure cultures from both clinical cases of
diarrheic and non-diarrheic healthy pen-mates.
Surprisingly, the general prev lence of str ins encoding genes for virulence factors, as well as
the presence of the typical E. coli pathotypes, was low in our pig population studied. Merely 26%
(32/122) of the strains could be classified into a specific pathotype. EPEC w s the most frequ nt one,
representing 14% of the total isolates, followed by ETEC (12%) and VTEC (3%). T e presenc of EPEC
is usually reported as a caus tive g nt f diarrhea, principally i post-weaned but also i suckling
pigs, b t in this study, the presence of this pathotype was found more prevalent i non-di rrheic piglets
(21.4%) than in the diarrheic on (11.8%). Similar results have been reported in previous works in
agreement with the results presented in the present study. Mainly, EPEC preval nce ranging from
3% to 26% in diarrheic animals and 9% to 17% in non-diarrheic animals has been described [26–28].
Finally, EAST1 gene w s highly detected in both diarrheic (70%) and no -di rr eic groups (86%) but
again with no relationship wit t e clinical onset. The EAST1 toxin is produced by several E. coli
pathotypes [29], and althoug initially it was believed to be involved in the athog nesis of diarrhea,
most author have concluded t at this toxin may not be a virulence determinant, because it has been
co monly isolated from healthy animals as well [30,31].
On the contr ry, ETEC and VTEC were more frequently isolated from diarrheic samples, suggesting
a possible association between these pathotypes and th emergence of dis ase in 1-week-old piglets.
The AMR henotypes f the E. coli isolates showed a wide resistanc to sulfonami e , tetracyclin s
and aminopenicillins in both diarrheic and non-diarrheic piglets. High percentages of antimicrobial
resistance for amoxicillin and ceftiofur have been previously reported in pig farms from Catalonia [32].
However, other studies conducted in other regions of Spain [33] or in Ireland [34] reported lower
levels of resistance to tetracycline, sulfamethoxazole/trimethoprim, ampicillin and streptomycin. These
differences could be explained by the fact that Catalonia is one of the areas with greater density of pigs
in Europe and therefore is likely subjected to a high consumption of antibiotics.
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On the other hand, an interesting finding of this study was that E. coli isolates from diarrheic
cases additionally presented extended AMR to quinolones and aminoglycosides (gentamicin and
neomycin) compared to those from healthy pigs. These findings agree with other studies performed
in Ontario [35] and in Denmark [36], which found consistently higher frequencies of resistance in
diarrheic and ETEC isolates, respectively.
The genotyping study showed that the E. coli strains containing the blaCTX-M gene presented
resistance to third- and fourth-generation cephalosporins, amoxicillin/clavulanic acid, quinolones
and aminoglycosides. The relationship between ESBLs and quinolone resistance mechanisms has
been documented by several authors [37–39], and it has been suggested that ESBL genes and
plasmid-mediated quinolone resistance are located within the same plasmid [40]. Furthermore, strains
harboring the blaCTX-M gene presented higher values of phenotypical resistance than those without
this gene, mainly to all the tested beta-lactams, quinolones and gentamicin.
Regarding the genotyping of the CTX-M+ strains, all the allelic variants described in this study
have previously been reported in pigs, with CTX-M-14 also being the most prevalent [41,42]
In the case of colistin, resistance was assessed using two different methods, the disk diffusion
method and the MIC test, finding low concordance between both techniques. According to several
authors, the disk diffusion method does not seem to be a reliable method for testing the efficacy of
colistin due to the poor diffusion of polymyxins in agar. Therefore, the use of other tests, such as MIC,
is more adequate for testing the susceptibility of colistin [43].
In general, the prevalence of porcine colistin-resistant E. coli strains reported in Europe is low:
0.9% in Poland [44], 1.5% in France [45], 2.9% in Germany [46] and 3.7% in Switzerland [47]. These
results are in concordance with the 5% of prevalence obtained in this study using the MIC test.
Nevertheless, García et al. (2018) have reported an extremely high prevalence of colistin resistance
(77%) in the northwest area of Spain [48]. Variations in animal health management, biosecurity and
sanitation procedures in pig production between different regions of the same country could explain
this different colistin-resistance prevalence.
Likewise, the prevalence of E. coli isolates harboring the mcr-1 gene was low (3%) in this study,
in agreement with results reported in Germany [46,49] and Belgium [50] with prevalence below 10%.
Nevertheless, prevalences of 26% and 88% have been published in studies conducted in the north-west
area of Spain [48] and in France [51], respectively. Only one E. coli isolate of this study presented the
mcr-4 gene; however, the frequency of this gene in the Spanish pig farms is variable, ranging from
21% [8] to 73% [48] depending of the region. Regarding other mcr genes, none of the isolates of this
study were positive for mcr-2, mcr-3 or mcr-5. The mcr-2 gene has been detected in porcine and bovine
E. coli isolates from Belgium [50], mcr-3 in E. coli isolates from pigs in UK [52] and mcr-5 in 3.4% of
isolates in Spain [48].
In summary, E. coli CTX-M+ strains isolated from diseased piglets showed antimicrobial
multi-resistance to β-lactams, tetracyclines, sulfonamides and lincospectin extended to quinolones and
aminoglycosides. This high prevalence of E. coli MDR strains in the pig population can represent a
serious threat for animal and human health [53].
5. Conclusions
More appropriate diagnostic approaches, including genetic and phenotypic analysis of AMR
profiles, should be implemented in animal health to optimize the use of antibiotics for treating diseased
animals when necessary and with an effective antimicrobial agent, as the presence of highly resistant
strains harboring ESBL and mcr genes circulating in pig farms can represent a potential threat to animal
and human health.
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